237 related articles for article (PubMed ID: 16025138)
1. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Gaskari SA; Liu H; Moezi L; Li Y; Baik SK; Lee SS
Br J Pharmacol; 2005 Oct; 146(3):315-23. PubMed ID: 16025138
[TBL] [Abstract][Full Text] [Related]
2. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS
Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
[TBL] [Abstract][Full Text] [Related]
3. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
[TBL] [Abstract][Full Text] [Related]
4. Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids.
Gaskari SA; Liu H; D'Mello C; Kunos G; Lee SS
J Hepatol; 2015 Jun; 62(6):1272-7. PubMed ID: 25640062
[TBL] [Abstract][Full Text] [Related]
5. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Liu H; Ma Z; Lee SS
Gastroenterology; 2000 May; 118(5):937-44. PubMed ID: 10784593
[TBL] [Abstract][Full Text] [Related]
6. Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy.
Jaue DN; Ma Z; Lee SS
Hepatology; 1997 Jun; 25(6):1361-5. PubMed ID: 9185753
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.
Bátkai S; Mukhopadhyay P; Harvey-White J; Kechrid R; Pacher P; Kunos G
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1689-95. PubMed ID: 17557913
[TBL] [Abstract][Full Text] [Related]
8. Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat.
Liu H; Song D; Lee SS
Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G68-74. PubMed ID: 11123199
[TBL] [Abstract][Full Text] [Related]
9. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats.
Ma Z; Miyamoto A; Lee SS
Gastroenterology; 1996 Apr; 110(4):1191-8. PubMed ID: 8613009
[TBL] [Abstract][Full Text] [Related]
10. Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy.
Ma Z; Lee SS; Meddings JB
J Hepatol; 1997 Apr; 26(4):904-12. PubMed ID: 9126806
[TBL] [Abstract][Full Text] [Related]
11. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.
Domenicali M; Ros J; Fernández-Varo G; Cejudo-Martín P; Crespo M; Morales-Ruiz M; Briones AM; Campistol JM; Arroyo V; Vila E; Rodés J; Jiménez W
Gut; 2005 Apr; 54(4):522-7. PubMed ID: 15753538
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers.
Yang YY; Lee KC; Huang YT; Lee FY; Chau GY; Loong CC; Lin HC; Lee SD
Liver Int; 2009 May; 29(5):678-85. PubMed ID: 19413671
[TBL] [Abstract][Full Text] [Related]
13. Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats.
Ebrahimi F; Tavakoli S; Hajrasouliha AR; Shafaroodi H; Sadeghipour H; Riazi K; Borhani AA; Houshmand G; Ahmadi SH; Dehpour AR
Eur J Pharmacol; 2005 Oct; 523(1-3):93-100. PubMed ID: 16226248
[TBL] [Abstract][Full Text] [Related]
14. The role of lipophilic bile acids in the development of cirrhotic cardiomyopathy.
Zavecz JH; Battarbee HD
Cardiovasc Toxicol; 2010 Jun; 10(2):117-29. PubMed ID: 20414815
[TBL] [Abstract][Full Text] [Related]
15. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes.
Al Kury LT; Voitychuk OI; Ali RM; Galadari S; Yang KH; Howarth FC; Shuba YM; Oz M
Cell Calcium; 2014 Feb; 55(2):104-18. PubMed ID: 24472666
[TBL] [Abstract][Full Text] [Related]
16. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
[TBL] [Abstract][Full Text] [Related]
17. Cirrhotic cardiomyopathy: an endocannabinoid connection?
Pacher P; Bátkai S; Kunos G
Br J Pharmacol; 2005 Oct; 146(3):313-4. PubMed ID: 16025137
[No Abstract] [Full Text] [Related]
18. The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis.
Hasanein P
Neurosci Lett; 2009 Oct; 462(3):230-4. PubMed ID: 19616063
[TBL] [Abstract][Full Text] [Related]
19. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
Chiba T; Ueno S; Obara Y; Nakahata N
J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids.
Yang YY; Liu H; Nam SW; Kunos G; Lee SS
J Hepatol; 2010 Aug; 53(2):298-306. PubMed ID: 20626112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
